The Breast Cancer Classifier refines molecular breast cancer classification to delineate the HER2-low subtype

Abstract Current breast cancer classification methods, particularly immunohistochemistry and PAM50, face challenges in accurately characterizing the HER2-low subtype, a therapeutically relevant entity with distinct biological features. This notable gap can lead to misclassification, resulting in ina...

Description complète

Détails bibliographiques

Auteurs principaux:	Polina Turova, Vladimir Kushnarev, Oleg Baranov, Anna Butusova, Sofia Menshikova, Sheila T. Yong, Anna Nadiryan, Zoia Antysheva, Svetlana Khorkova, Mariia V. Guryleva, Alexander Bagaev, Jochen K. Lennerz, Konstantin Chernyshov, Nikita Kotlov
Format:	Artigo
Langue:	Inglês
Publié:	Nature Portfolio 2025-02-01
Collection:	npj Breast Cancer
Accès en ligne:	https://doi.org/10.1038/s41523-025-00723-0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!